BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 210,587,372
- Total 13F shares
- 149,200,472
- Share change
- -3,563,805
- Total reported value
- $1,879,908,994
- Put/Call ratio
- 45%
- Price per share
- $12.60
- Number of holders
- 218
- Value change
- -$39,491,355
- Number of buys
- 104
- Number of sells
- 81
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
6.6%
|
13,987,418
|
$147,984,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
13,810,173
|
$146,112,000 | — | 30 Jun 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
6%
|
12,710,818
|
$134,480,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
5.2%
|
11,004,803
|
$116,431,000 | — | 30 Jun 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3.1%
|
6,500,000
|
$68,770,000 | — | 30 Jun 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
2.9%
|
6,046,961
|
$63,977,000 | — | 30 Jun 2022 | |
| Fisher Asset Management, LLC |
13F
|
Company |
2.5%
|
5,216,829
|
$55,194,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
2.5%
|
5,187,777
|
$54,887,000 | — | 30 Jun 2022 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
2.2%
|
4,564,930
|
$48,297,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
4,375,569
|
$46,294,000 | — | 30 Jun 2022 | |
| RP Management, LLC |
13F
|
Company |
1.8%
|
3,846,154
|
$40,692,000 | — | 30 Jun 2022 | |
| Fairmount Funds Management LLC |
13F
|
Company |
1.6%
|
3,343,107
|
$35,370,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
3,282,157
|
$34,725,000 | — | 30 Jun 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.5%
|
3,177,871
|
$33,622,000 | — | 30 Jun 2022 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.4%
|
2,917,209
|
$30,864,000 | — | 30 Jun 2022 | |
| PFM Health Sciences, LP |
13F
|
Company |
1%
|
2,162,411
|
$22,878,000 | — | 30 Jun 2022 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1%
|
2,099,327
|
$22,211,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.99%
|
2,083,412
|
$22,042,000 | — | 30 Jun 2022 | |
| NORGES BANK |
13F
|
Company |
0.94%
|
1,985,365
|
$21,005,162 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.93%
|
1,948,595
|
$20,616,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.91%
|
1,925,834
|
$20,375,000 | — | 30 Jun 2022 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.88%
|
1,850,024
|
$19,573,000 | — | 30 Jun 2022 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.87%
|
1,823,209
|
$19,292,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
1,816,884
|
$19,223,000 | — | 30 Jun 2022 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.86%
|
1,805,072
|
$19,097,000 | — | 30 Jun 2022 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.69%
|
1,461,091
|
$15,458,000 | — | 30 Jun 2022 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.66%
|
1,390,790
|
$14,715,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
1,376,712
|
$14,566,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.64%
|
1,357,003
|
$14,358,000 | — | 30 Jun 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.57%
|
1,200,000
|
$12,696,000 | — | 30 Jun 2022 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.57%
|
1,194,511
|
$12,638,000 | — | 30 Jun 2022 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.55%
|
1,168,345
|
$12,361,000 | — | 30 Jun 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.52%
|
1,101,611
|
$11,655,000 | — | 30 Jun 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.49%
|
1,022,376
|
$10,817,000 | — | 30 Jun 2022 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.44%
|
936,563
|
$9,909,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.36%
|
762,408
|
$8,066,000 | — | 30 Jun 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.34%
|
708,919
|
$7,500,000 | — | 30 Jun 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.31%
|
644,100
|
$6,815,000 | — | 30 Jun 2022 | |
| MPM BioImpact LLC |
13F
|
Company |
0.3%
|
639,089
|
$6,762,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
619,871
|
$6,559,000 | — | 30 Jun 2022 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
603,994
|
$6,390,000 | — | 30 Jun 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.28%
|
586,807
|
$6,209,000 | — | 30 Jun 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.27%
|
569,149
|
$6,023,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.26%
|
549,040
|
$5,809,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
542,461
|
$5,739,000 | — | 30 Jun 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.21%
|
445,675
|
$4,715,000 | — | 30 Jun 2022 | |
| North Star Investment Management Corp. |
13F
|
Company |
0.21%
|
441,900
|
$4,675,000 | — | 30 Jun 2022 | |
| Swiss National Bank |
13F
|
Company |
0.21%
|
434,968
|
$4,602,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.19%
|
405,888
|
$4,294,000 | — | 30 Jun 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.18%
|
387,327
|
$4,098,000 | — | 30 Jun 2022 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q3 2022
As of 30 Sep 2022,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
149,200,472 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, STATE STREET CORP, Avoro Capital Advisors LLC, FMR LLC, Fisher Asset Management, LLC, PICTET ASSET MANAGEMENT SA, RP Management, LLC, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
218
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
207
Q3 2022 holders
218
Holder diff
11
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.